These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2498861)

  • 1. Binding of sulfonamides to carbonic anhydrase: influence on distribution within blood and on pharmacokinetics.
    Boddy A; Edwards P; Rowland M
    Pharm Res; 1989 Mar; 6(3):203-9. PubMed ID: 2498861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent pharmacokinetics of L-693,612, a carbonic anhydrase inhibitor, following oral administration in rats.
    Wong BK; Bruhin PJ; Lin JH
    Pharm Res; 1994 Mar; 11(3):438-41. PubMed ID: 8008713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and stereoselective binding of the enantiomers of MK-927, a potent carbonic anhydrase inhibitor, by human erythrocytes in vitro.
    Lin JH; Lin TH; Cheng H
    Pharm Res; 1992 Mar; 9(3):339-44. PubMed ID: 1614967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saturable binding of indisulam to plasma proteins and distribution to human erythrocytes.
    Zandvliet AS; Copalu W; Schellens JH; Beijnen JH; Huitema AD
    Drug Metab Dispos; 2006 Jun; 34(6):1041-6. PubMed ID: 16565173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nuclear-magnetic-resonance study of the binding of novel N-hydroxybenzenesulphonamide carbonic anhydrase inhibitors to native and cadmium-111-substituted carbonic anhydrase.
    Blackburn GM; Mann BE; Taylor BF; Worrall AF
    Eur J Biochem; 1985 Dec; 153(3):553-8. PubMed ID: 3935439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel assay for erythrocyte carbonic anhydrase and certain sulfonamide drugs employing spin-labels.
    Chignell CF; Starkweather DK
    Pharmacology; 1972; 8(4):368-76. PubMed ID: 4348672
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of mammalian erythrocyte carbonic anhydrases employing spin-labeled analogues of inhibitory sulfonamides.
    Wee VT; Feldmann RJ; Tanis RJ; Chignell CF
    Mol Pharmacol; 1976 Sep; 12(5):832-43. PubMed ID: 825721
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetics of carbonic anhydrase-inhibitor complex formation. a comparison of anion- and sulfonamide-binding mechanisms.
    Taylor PW; Burgen AS
    Biochemistry; 1971 Oct; 10(21):3859-66. PubMed ID: 4334280
    [No Abstract]   [Full Text] [Related]  

  • 10. The in vitro and in vivo inhibitory effects of some sulfonamide derivatives on rainbow trout (Oncorhynchus mykiss) erythrocyte carbonic anhydrase activity.
    Bülbül M; Hisar O; Beydemir S; Ciftçi M; Küfrevioğlu OI
    J Enzyme Inhib Med Chem; 2003 Aug; 18(4):371-5. PubMed ID: 14567552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superacid synthesis of halogen containing N-substituted-4-aminobenzene sulfonamides: new selective tumor-associated carbonic anhydrase inhibitors.
    Compain G; Martin-Mingot A; Maresca A; Thibaudeau S; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1555-63. PubMed ID: 22705188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance studies of carbonic anhydrase. III. Binding of sulfonamides.
    Pesando JM; Grollman AP
    Biochemistry; 1975 Feb; 14(4):689-93. PubMed ID: 234740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of some spin-labeled sulfonamides with bovine erythrocyte carbonic anhydrase B.
    Chignell CF; Starkweather DK; Erlich RH
    Biochim Biophys Acta; 1972 Jun; 271(1):6-15. PubMed ID: 4338939
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of novel acridine and bis acridine sulfonamides with effective inhibitory activity against the cytosolic carbonic anhydrase isoforms II and VII.
    Ulus R; Yeşildağ I; Tanç M; Bülbül M; Kaya M; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(18):5799-805. PubMed ID: 23910989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
    Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
    Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of complex formation between human carbonic anhydrase B and heterocyclic sulfonamides.
    King RW; Maren TH
    Mol Pharmacol; 1974 Mar; 10(2):344-8. PubMed ID: 4212119
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose-dependent stereopharmacokinetics of 5,6-dihydro-4H-4(isobutylamino)thieno(2,3-B)thiopyran-2-sulfonamide-7,7 -dioxide , a potent carbonic anhydrase inhibitor, in rats.
    Lin JH; Ulm EH; Los LE
    Drug Metab Dispos; 1991; 19(1):233-8. PubMed ID: 1673405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation constants for carbonic anhydrase--sulfonamide binding by high-performance liquid chromatography.
    Osborne WR; Tashian RE
    Anal Biochem; 1984 Mar; 137(2):302-6. PubMed ID: 6428265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of dorzolamide.
    Martens-Lobenhoffer J; Banditt P
    Clin Pharmacokinet; 2002; 41(3):197-205. PubMed ID: 11929320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of temperature on the binding of sulfonamides to carbonic anhydrase isoenzymes I, II, and IV.
    Conroy CW; Maren TH
    Mol Pharmacol; 1995 Sep; 48(3):486-91. PubMed ID: 7565629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.